UNSPSC 51334409: Fosenazide

This classification denotes an antipsychotic agent and antidepressant with the molecular formula C14H15N2O2P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 16C19Z7F4I, chemically known as (diphenylphosphinyl)acetic acid, hydrazide but generally known as fosenazide, which bears US NIH Compound Identifier 27918. European Medicines Agency schedules Fosenazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07794MIG. The term FOSENAZIDE is an International Non-Proprietary Name.

UNSPSC 51334409 Fosenazide is a Commodity code with minimal recent state and local procurement activity. The three opportunities posted under this code in 2026 involve naloxone procurement, direct-to-manufacturer prescription programs, and generic pharmaceutical supply — none of which align directly with fosenazide, a selective herbicide used primarily in agriculture. Seminole County, Florida's IFB for naloxone and drug deactivation systems; Texas HHS's RFI on direct-to-manufacturer pharmacy initiatives; and Minnesota's MMCAP RFP for generic pharmaceuticals and OTC products all represent health-care and pharmacy-benefit procurement rather than herbicide or chemical product sourcing. The code shows a mismatch between its nominal scope and recent solicitation activity, suggesting either tagging error or minimal current demand for fosenazide specifically within state and local government procurement channels.

State and local buyers do not appear to be actively procuring fosenazide under this code at present. The recent opportunities identified in the code's activity stream address pharmaceutical inventory, prescription fulfillment, and drug-deactivation systems—domains distinct from agricultural chemicals or herbicides. Without recent solicitations for fosenazide itself, there is no basis to characterize issuing-body composition, geographic concentration, or representative bid activity for the commodity. Firms pursuing this code should monitor for activity changes, but current signal suggests pursuit is not warranted unless fosenazide demand emerges through a different UNSPSC code or procurement pathway.